Author + information
- Received December 8, 1986
- Revision received September 19, 1987
- Accepted October 13, 1987
- Published online March 1, 1988.
- Hugo A. Katus, MD∗,
- Klaus W. Diederich, MD,
- Eike Hoberg, MD and
- Wolfgang Kübler, MD, FACC
- ↵∗Address for reprints: Hugo A Katus, MD, Universitatsklinik Heidelberg, Innere Medizin III (Kardiologie), Bergheimer Strasse 58, 6900 Heidelberg, West Germany.
To detect myocardial cell damage, serum samples of 42 consecutive patients with angina at rest were screened for cardiac myosin light chains, which were detected in 22 patients (52%). In 17 of these patients there was a persistent release of myosin light chains lasting until the 4th hospital day, whereas in 7 patients myosin light chains were only detectable during the initial 24 h after admission. The presence of myosin light chains correlated with signs of ischemia in the electrocardiogram (ECG) (p < 0.05) and with the extent of coronary artery narrowing (p < 0.05). Cardiac myosin light chains were elevated in serum only if there was a ≥75% diameter narrowing in at least one major vessel.
In all five patients who developed transmural myocardial infarction during the course of their hospital stay, myosin light chains were detectable ≥28 h before the diagnosis of myocardial infarction could be established by ECG criteria and conventional serum enzymes. Thus the detection of circulating cardiac myosin light chains enables one to identify a subgroup of patients with angina at rest having more severe coronary artery disease with a worse outcome.
☆ This study was supported by a grant from the Deutsche Forschungsgemeinschaft, Bonn, West Germany.
- Received December 8, 1986.
- Revision received September 19, 1987.
- Accepted October 13, 1987.